Publications

Williams ES, Ferriby LL, Haws LC, Paustenbach DJ, Harris MA. 2007. Assessment of potential human health risks posed by benzene in a commercial beverage. Society of Toxicology 46th Annual Meeting, Charlotte, NC, March 2007.

Ferriby LL, Williams ES, Lukesemburg WJ, Paustenbach DJ, Haws LC, Birnbaum LS, Harris M. Comparing polychlorinated biphenyls in farm-raised and wild-caught catfish from southern Mississippi. Dioxin 2006, Oslo, Norway, August 2006.

Ferriby LL, Williams ES, Lukesemburg WJ, Paustenbach DJ, Haws LC, Birnbaum LS, Harris M. Comparing PCDDs, PCDFs, and dioxin-like PCBs in farm-raised and wild-caught catfish from Southern Mississippi. Dioxin 2006, Oslo, Norway, August 2006.

Ferriby LL, Franke K, Unice KM, Scott P, Haws LC, Harris M, Paustenbach DJ. 2006. Serum reference levels of PCDD/Fs and dioxin-like PCBs stratified by race/ethnicity, gender and age for the general U.S. population. American Public Health Association Annual Meeting and Exposition. November 4-8, 2006. Boston, MA.

Haws L. The use of toxic equivalency factors to assess potential human health risks posed by dioxin-like compounds: Keeping up with the science. Presented at Michigan State University, Toxicology Program Seminar Series, September,, 2006.

Haws LC, Scott PK, Unice KM, Gough M, Harris MA, Staskal DF, Paustenbach DJ, Pavuk M. Are dioxin body burdens surrogates for other risk factors in associations between dioxin and diabetes? Dioxin 2006, Oslo, Norway, August 2006.

Van den Berg M, Birnbaum L, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws LC, Rose M, Safe S, Schrenk D, Tohyama C, Tritscher A, Tuomisto J, Tysklind M, Walke Nr, Peterson RE. 2006. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93(2):223-241; doi: 10.1093/toxsci/kfl055.

Haws LC, DeVito MJ, Birnbaum LS, Walker NJ, Scott PK, Unice KM, Harris MA, Farland WH, Finley BL, Staskal DF. An alternative method for establishing TEFs for dioxin-like compounds. Part 2. Development of an approach to quantitatively weight the underlying potency data. Dioxin 2006, Oslo, Norway, 2006.

Paustenbach DJ, Harris M, Ferriby LL, Williams ES, Haws LC, Unice KM, Scott PK. Development of PCDD/F TEQ serum reference values for the U.S. population for use in evaluating biomonitoring results. Dioxin 2006, Oslo, Norway, August 2006.

Staskal DF, Ferriby LL, Williams ES, Luksemburg WJ, Haws LC, Birnbaum LS, Paustenbach DJ, Harris M. 2006. Polybrominated diphenyl ethers in southern Mississippi catfish. Dioxin 2006, Oslo, Norway, August 2006.

Van den Berg M, Birnbaum L, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws LC, et al. Human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds: The WHO 2005 re-evaluation. Dioxin 2006, Oslo, Norway, August 2006.

Paustenbach DJ, Scott LLF, Nguyen LM, Unice KM, Scott P, Haws LC, Harris M. 2007. Referent concentrations of PCDD/Fs and dioxin-like PCBs in sera of persons in the U.S. Based on the New WHO 2006 TEFs and 2001-2002 NHANES data. Ann Epidemiol 17(9):734.

Haws L. Evaluating potential health risks posed by PCDDs, PCDFs, and dioxin-like PCBs: An approach for improving the Toxicity Equivalency Factor (TEF) methodology. 30th Annual Winter Meeting of the Toxicology Forum, Washington, DC, February 2005.

Haws, L. Roundtable: Is it time to reevaluate the toxic equivalency factors for PCDDs, PCDFs, and dioxin-like PCBs? The use of toxicity equivalence factors (TEFs) for PCDDs, PCDFs, and dioxin-like PCBs in risk assessment: Improving the process. Dioxin 2004. September Berlin, Germany, September 2004.

Haws L, Harris M, Su S, Birnbaum L, DeVito M, Farland W, Walker N, Connor K, Santamaria A, Finley B. Development of a refined database of relative potency estimates to facilitate better characterization of variability and uncertainty in the current mammalian TEFs for PCDDs, PDCFs, and dioxin-like PCBs. Dioxin 2004, Berlin, Germany, 2004.

Haws L, Harris M, Su S, Walker N, Birnbaum L, DeVito M, Farland W, Connor K, Santamaria A, Finley B. A preliminary approach to characterizing variability and uncertainty in the mammalian PCDD/F and PCB TEFs. Dioxin 2004, Berlin, Germany, 2004.

Haws L. Combustion risk modeling and assessment. Presented at the Texas Commission on Environmental Quality Workshop on Hazardous Waste Combustion, Austin, TX, May 2003.

Grant RL, Rodriguez R, Hofelt CS, and Haws LC. 2002. Shortcomings in USEPA’s approach for predicting risk due to consumption of animal food products impacted by air emissions from hazardous waste combustion facilities: A case study involving phthalates. Human Ecol Risk Assess 8(5):1137-1154; doi: 10.1080/1080-700291905855.

Haws L. Permitting of hazardous waste combustion facilities in the state of Texas: Human health risks associated with fugitive emissions sources. Presented at the Texas Chemical Council Quarterly Meeting. Houston, TX, August 2002.

Haws L. Texas risk reduction program rule-The basics. Question and Answer Forum Panelist. Presented at the Texas Natural Resource Conservation Commission Environmental Trade Fair. Waste Remediation Track, Austin, TX, May 2002.